Cary Street Partners Asset Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-527
Closed -$12.4K 333
2023
Q1
$12.4K Sell
527
-28
-5% -$752 ﹤0.01% 331
2022
Q4
$15.5K Sell
555
-324
-37% -$8.28K ﹤0.01% 341
2022
Q3
$21K Buy
+879
New +$26.5K 0.01% 281

Other funds holding OGN

Cary Street Partners Asset Management's OGN Position: Q2 2023 in Review

Cary Street Partners Asset Management sold out of Organon & Co (OGN) in Q2 2023, closing a stake of 527 shares — an estimated $12.4K sold.

Cary Street Partners Asset Management first reported a position in OGN in Q3 2022 and held it in 3 quarters. The position peaked at $21K in Q3 2022. 726 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

  • Cary Street Partners Asset Management reported no remaining Organon & Co position as of Q2 2023 after selling out during the quarter.
  • Cary Street Partners Asset Management sold 527 Organon & Co shares in Q2 2023, an estimated $12.4K.
  • Cary Street Partners Asset Management first reported a position in Organon & Co in Q3 2022 and held it in 3 quarters.
  • Cary Street Partners Asset Management's Organon & Co position peaked at $21K in Q3 2022.
  • 726 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on Cary Street Partners Asset Management's 13F filing for Q2 2023, filed 10 Aug 2023.